l-carnitine in management of valproic acid induced hyperammonemia

l-carnitine in management of valproic acid induced hyperammonemia Mechanism (VPA)-induced hyperammonemia. (1) VPA is L‐carnitine for valproic acid‐induced toxicity

Name: l-carnitine in management of valproic acid induced hyperammonemia Mechanism (VPA)-induced hyperammonemia. (1) VPA is L‐carnitine for valproic acid‐induced toxicity
Brand: equiscorp.hu
SKU: 12713047500
Price: 29.65 USD
Availability: InStock
Rating: 4.1143 (11 reviews)

Lcarnitine for valproic acidinduced toxicity PMC What is the role of Levocarnitine and Valproate (Depakote) in managing hyperammonemia? What is the recommended Lcarnitine dosing regimen for managing hyperammonemia in pediatric and adult patients? Science review: Carnitine in the treatment of valproic acid induced toxicity what is the evidence? PMC

SKU: 12713047500 · From equiscorp.hu

4.1

USD29.65 USD53.65

Pay in 4 interest-free payments of $7.41 Learn more

Shipping Estimate
USA

USA

CAN

Ships within 48 hours · Estimated delivery Aug 3 - Aug 8

Description

La L-carnitine, un acide amin produit naturellement par l'organisme, joue un rle cl dans le mtabolisme des graisses

250 ml de leche desnatada

The authors used the fixed-effect or random meta-analysis to evaluate the effect of L-carnitine versus placebo/ on the outcome when the data were available in at least two RCTs